Inositol 1,4,5-trisphosphate receptor phosphorylation in breast cancer.

Tumour Biol

Vascular Biology Laboratory, Department of Neurosurgery, St. Luke's Roosevelt Hospital Center, New York, N.Y. 10025, USA.

Published: September 2005

The aim of this study was to establish the type(s) of inositol 1,4,5-trisphosphate receptors (IP3Rs) in T47D breast cancer cells that regulate intracellular calcium (Ca2+) and whether they interact with cyclin (Cy), an important regulator of cyclin-dependent kinases (cdk), during cell cycle progression. Immunoblotting, immunoprecipitation, and pull-down assays were used to identify IP3R expression and interaction with Cy. The relative IP3R3 expression, as compared to IP3R1, was higher in these cells. Pull-down analysis showed that IP3R3 interacted with both CyA and CyB. The interaction with Cys and the phosphorylation of IP3Rs by Cy/cdk complexes provide a novel mechanism of regulating intracellular Ca2+ release and Ca2+-dependent signaling events in breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000086954DOI Listing

Publication Analysis

Top Keywords

breast cancer
12
inositol 145-trisphosphate
8
145-trisphosphate receptor
4
receptor phosphorylation
4
phosphorylation breast
4
cancer aim
4
aim study
4
study establish
4
establish types
4
types inositol
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!